MetaCap

Vericel Earnings

NASDAQ: VCELHealthcareBiotechnologyUSD

40.05-0.69 (-1.69%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

Next earnings date

Thu, Nov 5, 2026

Fiscal period

Sep/2026

EPS estimate

$0.02

Vericel earnings summary

Vericel is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $0.02. In its most recent report on Jul 30, 2026 (Q2 2026), VCEL posted EPS of $0.04. Revenue for the quarter was $77.5 million.

Across the last 16 reports, VCEL shares moved an average of 3.1% (in either direction) in the first trading session after results, rising 7 times and falling 9 times.

Summary generated from market data by MetaCap's automated system. Methodology

VCEL earnings history

Vericel reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Jul 30, 2026—$0.04—-1.9%
May 7, 2026—$-0.12—-1.3%
Feb 26, 2026—$0.46—-5.5%
Nov 6, 2025—$0.10—+2.4%
Jul 31, 2025—$-0.01—+1.7%
May 8, 2025—$-0.23—+1.8%
Feb 27, 2025—$0.40—-3.4%
Nov 7, 2024—$-0.02—-2.8%
Aug 1, 2024—$-0.10—-4.2%
May 8, 2024—$-0.08—+0.5%
Feb 29, 2024—$0.28—+1.1%
Nov 8, 2023—$-0.08—+7.9%
Aug 2, 2023—$-0.11—-1.0%
May 10, 2023—$-0.16—-0.9%
Feb 23, 2023—$0.13—+2.7%
Nov 9, 2022—$-0.14—-10.5%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related